Worse Mental Health Trajectories Seen for Survivors of Teen, Young Adult Cancer

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on May 28, 2025.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, May 28, 2025 -- Survivors of adolescent and young adulthood (AYA) cancer have significantly worse mental health trajectories into middle or older adulthood, according to a study published online May 19 in JAMA Network Open.

Anao Zhang, Ph.D., from the University of Michigan School of Social Work in Ann Arbor, and colleagues conducted a cohort study using cross-sectional data from the Health and Retirement Study to characterize mental health outcomes among U.S. adults older than 50 years, focusing on survivors of AYA cancer.

Data were obtained for 39,668 respondents: 374, 5,045, and 34,249 respondents reported having cancer in AYA, received a first-time cancer diagnosis after study onset as adults, and never had cancer, respectively. The researchers found that compared with other cohorts, survivors of AYA cancer had the highest prevalence of lifetime psychiatric issues (16.36 to 37.80 percent), prescription anxiety and/or depression medication (25.10 to 33.78 percent), and meeting major depression criteria (13.13 to 20.96 percent). AYA cancer survivors had higher odds of lifetime psychiatric issues (in four of 14 waves), similar odds of taking anxiety or depression medications, and higher odds of meeting major depression criteria (in three of seven waves) compared with adult cancer survivors and even after adjustment for demographic covariates. Age-dependent U-shaped trajectories were seen for depression and anxiety symptoms in linear mixed-effect growth models; mean levels of symptoms were significantly higher for AYA cancer survivors. Later in life, AYA cancer survivors had a flattening of anxiety symptoms.

"As the number of AYA cancer survivors continues to grow, it remains a critical priority to improve survivorship outcomes using a holistic approach," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-05-29 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords